Viewbix Eyes 85–100% Quantum X Labs Acquisition and $1.4M Financing
Viewbix agreed to acquire 85–100% of Israel’s Quantum X Labs in mid-December and raised $1.4M via a private placement of 800,000 units at $1.75; closing is expected within 90 days after stockholder consent and Schedule 14C filings. Quantum X Labs’ assets include quantum gyroscopes, error correction and biomedical methods.
1. Acquisition Details
In mid-December 2025, Viewbix signed a definitive agreement to acquire between 85% and 100% of Israel’s Quantum X Labs, gaining control of its expanding patent portfolio and interdisciplinary research platforms. The transaction underscores Viewbix’s strategic shift into quantum technologies, leveraging Quantum X Labs’ research ties with leading Israeli academic institutions.
2. Financing and Timeline
Viewbix amended its private placement in early January to issue 800,000 units at $1.75 each, raising approximately $1.4 million in gross proceeds plus a potential $1.68 million warrant kicker. The acquisition and financing are expected to close within 90 calendar days of the December 15 agreement, contingent on final due diligence, regulatory approvals, majority stockholder consent obtained January 5 and Schedule 14C filings made January 15.
3. Quantum X Labs Portfolio
Quantum X Labs’ portfolio spans multiple near-term quantum appl ications: Quantum Gyro for GPS-denied navigation, Quantum Transportation’s error-correction solutions, Cliniquantum’s quantum-enhanced biomedical analysis, Quantum Aton Accuracy for precision timing, QuantumQ Security for data protection and Nuclear Quantum’s reactor simulation advancements.